Preparation for resisting suppression of bone marrow after lung cancer chemotherapy
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 杨春玲
- Publication Date
- 2011-05-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a preparation for resisting bone marrow suppression after chemotherapy for lung cancer, which belongs to the field of traditional Chinese medicines. Background technique
[0002] As we all know, comprehensive treatment of lung cancer is an important measure to reduce tumor metastasis and improve survival rate of patients. Timely, appropriate and effective chemotherapy is very important; whether the chemotherapy cycle can be effectively completed is the key to determine the prognosis of patients. While chemotherapy inhibits or kills tumor cells, due to severe bone marrow suppression, it is most toxic to normal tissue cells, especially hematopoietic cells, thus affecting treatment. Therefore, bone marrow suppression is a major problem that restricts the therapeutic effect and prognosis of tumors.
[0003] So far, drugs such as Qiangli Shengbai Tablets and Granulocyte Colony Stimulating Factor have been used clinically, but due t...